Response to: ' Correspondence on 'Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension'' by Iudici et al

Ann Rheum Dis. 2023 Mar;82(3):e66. doi: 10.1136/annrheumdis-2020-219597. Epub 2020 Dec 16.

Ekkehard Grünig^{1

2}, Nicola Benjamin^{3

2}, Panagiota Xanthouli^{1

2}, Suzana Jordan⁴, Nicklas Milde^{1

2}, Alberto Marra⁵, Norbert Blank⁶, Benjamin Egenlauf^{1

2}, Matthias Gorenflo⁷, Satenik Harutyunova^{1

2}, Hanns-Martin Lorenz⁶, Christian Nagel^{1

2

8}, Vivienne Theobald^{1

2}, Mona Lichtblau⁹, Charlotte Berlier⁹, Silvia Ulrich⁹, Oliver Distler⁴

¹ Centre for Pulmonary Hypertension, Thoraxklinik-Heidelberg gGmbH at Heidelberg University Hospital, Heidelberg, Germany.
² Translational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research, Heidelberg, Germany.
³ Centre for Pulmonary Hypertension, Thoraxklinik-Heidelberg gGmbH at Heidelberg University Hospital, Heidelberg, Germany nicola.benjamin@med.uni-heidelberg.de.
⁴ Department of Rheumatology, University of Zurich, University Hospital Zurich, Zurich, Switzerland.
⁵ IRCCS SDN Naples, Naples, Italy.
⁶ Department of Internal Medicine 5: Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.
⁷ Department of Pediatric Cardiology, University Hospital Heidelberg, Heidelberg, Baden-Württemberg, Germany.
⁸ Lung Centre, Klinikum Mittelbaden gGmbH, Baden-Baden, Baden-Württemberg, Germany.
⁹ Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland.

No abstract available

Keywords: epidemiology; hypertension; scleroderma; systemic.

Publication types